TLR4 Cross-Talk With NLRP3 Inflammasome and Complement Signaling Pathways in Alzheimer's Disease
Amyloid plaques, mainly composed of abnormally aggregated amyloid β-protein (Aβ) in the brain parenchyma, and neurofibrillary tangles (NFTs), consisting of hyperphosphorylated tau protein aggregates in neurons, are two pathological hallmarks of Alzheimer's disease (AD). Aβ fibrils and tau aggre...
Main Authors: | Junling Yang, Leslie Wise, Ken-ichiro Fukuchi |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-04-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2020.00724/full |
Similar Items
-
Salidroside Ameliorates Alzheimer's Disease by Targeting NLRP3 Inflammasome-Mediated Pyroptosis
by: Yawen Cai, et al.
Published: (2022-01-01) -
Prognostic Value of NLRP3 Inflammasome and TLR4 Expression in Breast Cancer Patients
by: Concetta Saponaro, et al.
Published: (2021-09-01) -
Terminal complement pathway activation drives synaptic loss in Alzheimer’s disease models
by: Sarah M. Carpanini, et al.
Published: (2022-07-01) -
Distinct effects of complement and of NLRP3- and non-NLRP3 inflammasomes for choroidal neovascularization
by: Jakob Malsy, et al.
Published: (2020-12-01) -
Inflammasome signaling is dispensable for ß-amyloid-induced neuropathology in preclinical models of Alzheimer’s disease
by: Sahana Srinivasan, et al.
Published: (2024-01-01)